INFORMATION:
About Mayo Clinic
Mayo Clinic is a nonprofit organization committed to innovation in clinical practice, education and research, and providing compassion, expertise and answers to everyone who needs healing. Visit the Mayo Clinic News Network for additional Mayo Clinic news. For information on COVID-19, including Mayo Clinic's Coronavirus Map tracking tool, which has 14-day forecasting on COVID-19 trends, visit the Mayo Clinic COVID-19 Resource Center.
Newly discovered genetic variants in a single gene cause neurodevelopmental disorder
2021-07-01
(Press-News.org) Rochester, Minn. -- Mayo Clinic researchers have discovered that genetic variants in a neuro-associated gene called SPTBN1 are responsible for causing a neurodevelopmental disorder. The study, published in Nature Genetics, is a first step in finding a potential therapeutic strategy for this disorder, and it increases the number of genes known to be associated with conditions that affect how the brain functions.
"The gene can now be included in genetic testing for people suspected of having a neurodevelopmental disorder, which may end the diagnostic odyssey these people and their families have endured," says Margot Cousin, Ph.D., a translational genomics researcher in Mayo Clinic's Center for Individualized Medicine and the study's lead author.
For the global study, a collaboration with The University of North Carolina at Chapel Hill, researchers investigated disease-causing variants of the SPTBN1 gene in 29 people with clinical neurodevelopmental symptoms, including language and motor delays, intellectual disability, autistic features, seizures, behavioral and movement abnormalities, and variable dysmorphic facial features. Overall, the team identified 28 unique variants.
Dr. Cousin says most of the genetic variants were not inherited, but rather newly occurred in the patients who were affected.
"We showed through multiple different model systems, including computational protein modeling, human- and mouse cell-based systems, patient-derived cell systems, and in vivo mouse studies, the impact the variants have on the function of the protein encoded by the SPTBN1 gene," Dr. Cousin explains. "I had a hunch this gene was the answer for these patients, but it wasn't until we accrued and studied more patients with variants in SPTBN1 that we could see how the variants had damaging effects on the protein and we could begin putting the story together."
The SPTBN1 gene codes for a protein called beta-two spectrin, which is abundantly expressed in the brain and other parts of the body. Beta-two spectrin makes protein networks within cells, and it is essential for the brain's development and connectivity.
"Interestingly, some of the variants behave very differently than the others, where some make the beta-two spectrin protein unstable and some disrupt its ability to make important interactions with other proteins," Dr. Cousin says. "But these differences in functional effects helped to explain the clinical variability we were observing in the patients."
The study also demonstrates the challenges in rare disease genomics, as many neurodevelopmental diseases remain undiagnosed under the standard of care.
But Dr. Cousin is hopeful the tide is turning.
"Advances in genome sequencing and our ability to interpret the enormous amount of data we generate with various types of 'omic' technologies has led to increases in the discovery of novel disease-causing genes," Dr. Cousin says. "But rigorous studies encompassing the clinical manifestations of affected people and the underlying mechanism of disease are often critical to solidifying a new gene-disease relationship."
Omic technologies include the detection of genes, genomics; messenger RNA, transcriptomics; proteins, proteomics; and metabolites, metabolomics.
Dr. Cousin emphasizes that bringing this genetic finding to light required much perseverance.
"The clinical variability we observed in people early on was not very compelling that this could be a single genetic condition," she explains. "The gene, however, had many of the hallmarks of a rare monogenic disease gene, including that the normal population doesn't have variation in SPTBN1, other spectrin genes cause neurological syndromes, and mouse studies completely lacking the protein have severe defects."
Dr. Cousin says the cell-based and animal models developed in the study will continue to be invaluable in advancing knowledge of the disease mechanisms and testing any potential therapeutic strategies.
"While there is not yet a specific treatment available for people affected by SPTBN1-associated disease, we can now provide patients with an answer to the root cause of disease, which is the most important first step toward finding a cure."
ELSE PRESS RELEASES FROM THIS DATE:
Scientists resurrect 'forgotten' genus of algae living in marine animals
2021-07-01
UNIVERSITY PARK, Pa. -- In the late 1800s, scientists were stumped by the "yellow cells" they were observing within the tissues of certain temperate marine animals, including sea anemones, corals and jellyfish. Were these cells part of the animal or separate organisms? If separate, were they parasites or did they confer a benefit to the host?
In a paper published in the journal Nature in 1882, biologist Sir Patrick Geddes of Edinburgh University proffered that not only were these cells distinct entities, but they were also beneficial to the animals in which they lived. He assigned them to a new genus, Philozoon -- from the Greek phileo, meaning 'to love ...
For women workers in India, direct deposit is 'digital empowerment'
2021-07-01
Giving women in India's Madhya Pradesh state greater digital control over their wages encouraged them to enter the labor force and liberalized their beliefs about working women, concluded a new study co-authored by Yale economists Rohini Pande and Charity Troyer Moore.
The study, published in the American Economic Review, found that a relatively simple intervention directed to poor women -- providing them access to their own bank accounts and direct deposit for their earnings from a federal workfare program, along with basic training on how to use local bank kiosks -- increased the amount ...
The rise and fall of elephants
2021-07-01
Based on fossil finds, we know that the vast majority of species that once inhabited the earth have become extinct. For example, there are about 5,500 mammal species living on the planet today, but we know of at least 160,000 fossil species, so for every mammal species living today, there are at least 30 extinct ones. We therefore know with great certainty that the lineages of living things come and go along immense time scales. But what factors cause these lineages to come into being and disappear is still an unsolved question.
To investigate ...
Using AI to predict 3D printing processes
2021-07-01
Additive manufacturing has the potential to allow one to create parts or products on demand in manufacturing, automotive engineering, and even in outer space. However, it's a challenge to know in advance how a 3D printed object will perform, now and in the future.
Physical experiments -- especially for metal additive manufacturing (AM) -- are slow and costly. Even modeling these systems computationally is expensive and time-consuming.
"The problem is multi-phase and involves gas, liquids, solids, and phase transitions between them," said University of Illinois Ph.D. student Qiming ...
Mefloquine: A promising drug 'soldier' in the battle against COVID-19
2021-07-01
Early 2020 saw the world break into what has been described as a "war-like situation": a pandemic, caused by the severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2), the likes of which majority of the living generations across most of the planet have not ever seen. This pandemic has downed economies and resulted in hundreds of thousands of deaths. At the dawn of 2021, vaccines have been deployed, but before populations can be sufficiently vaccinated, effective treatments remain the need of the hour.
Thus, other than fast-tracking research into novel drugs, scientists have also been exploring their ...
New approach can add diversity to crop species without breeding GMOs
2021-07-01
Breeding better crops through genetic engineering has been possible for decades, but the use of genetically modified plants has been limited by technical challenges and popular controversies. A new approach potentially solves both of those problems by modifying the energy-producing parts of plant cells and then removing the DNA editing tool so it cannot be inherited by future seeds. The technique was recently demonstrated through proof-of-concept experiments published in the journal Nature Plants by geneticists at the University of Tokyo.
"Now we've got a way to modify chloroplast genes specifically and measure their potential to make a good plant," said Associate Professor Shin-ichi ...
How children integrate information
2021-07-01
"We know that children use a lot of different information sources in their social environment, including their own knowledge, to learn new words. But the picture that emerges from the existing research is that children have a bag of tricks that they can use", says Manuel Bohn, a researcher at the Max Planck Institute for Evolutionary Anthropology.
For example, if you show a child an object they already know - say a cup - as well as an object they have never seen before, the child will usually think that a word they never heard before belongs with the new object. Why? Children use information ...
Last ice-covered parts of summertime Arctic Ocean vulnerable to climate change
2021-07-01
In a rapidly changing Arctic, one area might serve as a refuge - a place that could continue to harbor ice-dependent species when conditions in nearby areas become inhospitable. This region north of Greenland and the islands of the Canadian Arctic Archipelago has been termed the Last Ice Area. But research led by the University of Washington suggests that parts of this area are already showing a decline in summer sea ice.
Last August, sea ice north of Greenland showed its vulnerability to the long-term effects of climate change, according to a study published July 1 in the open-access journal Communications Earth & Environment.
"Current thinking is that this area may be the last refuge for ice-dependent ...
Global climate dynamics drove the decline of mastodonts and elephants, new study suggests
2021-07-01
Elephants and their forebears were pushed into wipeout by waves of extreme global environmental change, rather than overhunting by early humans, according to new research.
The study, published today in Nature Ecology & Evolution, challenges claims that early human hunters slaughtered prehistoric elephants, mammoths and mastodonts to extinction over millennia. Instead, its findings indicate the extinction of the last mammoths and mastodonts at the end of the last Ice Age marked the end of progressive climate-driven global decline among elephants over millions of years.
Although elephants today are restricted to just three endangered species in the African and Asian tropics, these are survivors of a once far more diverse and widespread group of giant herbivores, known ...
Multimodality care improves treatment outcomes for aggressive prostate cancer
2021-07-01
FINDINGS
Men with high-risk prostate cancer with at least one additional aggressive feature have the best outcomes when treated with multiple healthcare disciplines, known as multimodality care, according to a UCLA study led by Dr. Amar Kishan, assistant professor of radiation oncology at the David Geffen School of Medicine at UCLA and a researcher at the UCLA Jonsson Comprehensive Cancer Center.
The study found no difference in prostate cancer-specific deaths across treatment modalities when patients received guideline-concordant multimodality therapy, which in this case was inclusion of hormone therapy for men receiving radiation ...